(Q51305168)

3 April 2018

title

Caloric restriction ameliorates cardiomyopathy in animal model of diabetes. (English)

1 reference

3 April 2018

1 reference

3

Nader G Abraham

1 reference

3 April 2018

Michal Laniado-Schwartzman

4

object named as

Michal Laniado-Schwartzman

1 reference

3 April 2018

author name string

Keren Cohen

1

1 reference

3 April 2018

Maayan Waldman

2

1 reference

3 April 2018

Danny Gurfield

5

1 reference

3 April 2018

Dan Aravot

6

1 reference

3 April 2018

Michael Arad

7

1 reference

3 April 2018

Edith Hochhauser

8

1 reference

3 April 2018

language of work or name

English

0 references

publication date

21 November 2016

1 reference

3 April 2018

Experimental Cell Research

published in

1 reference

3 April 2018

volume

350

1 reference

3 April 2018

issue

1

1 reference

3 April 2018

page(s)

147-153

1 reference

3 April 2018

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Oxidative stress and myocardial injury in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Development of heart failure in recent hypertension trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Diabetic cardiomyopathy: pathophysiology and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Profibrotic effects of angiotensin II in the heart: a matter of mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Abnormal splicing of the leptin receptor in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Innate immune recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

LPS/TLR4 signal transduction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Mechanisms of obesity-associated insulin resistance: many choices on the menu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Silencing cardiomyocyte TLR4 reduces injury following hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Relative neuroprotective effects hyperbaric oxygen treatment and TLR4 knockout in a mouse model of temporary middle cerebral artery occlusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Fat uses a TOLL-road to connect inflammation and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

TLR4 links innate immunity and fatty acid-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Plasma fetuin-A levels and the risk of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Long-Lived αMUPA Mice Show Attenuation of Cardiac Aging and Leptin-Dependent Cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

An ultra-low dose of tetrahydrocannabinol provides cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Insulin resistance and heart failure: molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Preliminary analysis of immune activation in early onset type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-like receptor signaling: defensive or offensive for the heart?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Innate immunity and cardiomyocytes in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Caloric restriction in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Free fatty acids (FFA), a link between obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Cardioprotective Signature of Short-Term Caloric Restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.11.016

10.1016/J.YEXCR.2016.11.016

7 January 2021

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018